Medical News

---

• Cytomegalovirus pneumonitis increases risk for BOS in lung transplant patients
• Nutritional drink may reduce airway inflammation in asthmatic children
• Confounding by indication may explain asthma link to antibiotic use
• Bipolar I and II patients show abnormal white matter differences
• Age at psychosis onset not influenced by cannabis use disorders
• Low INR target suitable for AVR patients
• Even lacunar stroke patients benefit from organized care
• Initial PSA measurement can predict risk for prostate cancer death
• Preferences of older breast cancer patients linked to chemotherapy rate
• Initial PSA measurement can predict risk for prostate cancer death
• High fish oil intake has no mortality benefit for CAD patients
• CRP impact on mortality questioned
• BARI-2D results suggest rosiglitazone may not cause CV events
• Moderate-dose aspirin linked to lower all-cause mortality in diabetics
• No cardiac, pulmonary dysfunction found in ticagrelor-induced dyspnea
• INVEST in print: Tight diabetic BP control not linked to improved CVD outcomes
• Preferences of older breast cancer patients linked to chemotherapy rate
• Modulating miR-145 could destroy prostate cancer cells
• Bone metastasis occurs in post-surgery prostate patients, even at low PSA
• Breast cancer chemotherapy linked to cognitive dysfunction
• HIFU for prostate cancer shows promising oncologic outcomes
• New drug shows promise for <i>BRCA</i>-related cancers
• Undetectable ultrasensitive PSA predicts recurrence-free survival in RP patients
• Heterocyclic amines not linked to prostate cancer across ethnicities
• Complementary medicine use documented in women with breast cancer

Cytomegalovirus pneumonitis increases risk for BOS in lung transplant patients Posted: 08 Jul 2010 05:00 PM PDT Cytomegalovirus pneumonitis affects around a fifth of lung transplant patients and is associated with an increased risk for bronchiolitis obliterans syndrome (BOS) and death, research shows.

Nutritional drink may reduce airway inflammation in asthmatic children Posted: 08 Jul 2010 05:00 PM PDT A nutritional drink rich in beneficial fatty acids and antioxidants may help reduce levels of airway inflammation in children with asthma, US research suggests.

Confounding by indication may explain asthma link to antibiotic use Posted: 08 Jul 2010 05:00 PM PDT Results from a US study suggest the increased risk for childhood asthma associated with antibiotic use may be a result of confounding by indication.

Bipolar I and II patients show abnormal white matter differences Posted: 08 Jul 2010 05:00 PM PDT Patients with bipolar I and bipolar II disorder have distinct neuropathological substrates, study findings show.

Age at psychosis onset not influenced by cannabis use disorders Posted: 08 Jul 2010 05:00 PM PDT Cannabis use disorders (CUD) do not appear to influence age at onset of psychosis, although they do often precede the onset of illness, researchers report.

Low INR target suitable for AVR patients Posted: 07 Jul 2010 05:00 PM PDT Results from the LOWERING-IT trial support the use of a moderate oral anticoagulation regimen in low risk patients following mechanical aortic valve replacement.

Even lacunar stroke patients benefit from organized care Posted: 07 Jul 2010 05:00 PM PDT Stroke patients benefit from organized care regardless of the etiology of their stroke, research shows.

Initial PSA measurement can predict risk for prostate cancer death Posted: 07 Jul 2010 05:00 PM PDT A man's initial prostate-specific antigen measurement can independently predict his risk for death from prostate cancer, show US study results.

Preferences of older breast cancer patients linked to chemotherapy rate Posted: 07 Jul 2010 05:00 PM PDT A strong preference for chemotherapy and good patient–physician communication are associated with higher rates of chemotherapy use in older women with breast cancer, US research shows.

Initial PSA measurement can predict risk for prostate cancer death Posted: 07 Jul 2010 05:00 PM PDT A man's initial prostate-specific antigen measurement can independently predict his risk for death from prostate cancer, show US study results.

High fish oil intake has no mortality benefit for CAD patients Posted: 07 Jul 2010 05:00 PM PDT Fish oil consumption is not associated with reduced coronary risk among patients with stable coronary artery disease who already have a relatively high intake, research shows.

CRP impact on mortality questioned Posted: 07 Jul 2010 05:00 PM PDT C-reactive protein is a robust marker of all-cause mortality risk but may not itself directly affect mortality risk, shows an analysis of the Copenhagen City Heart Study.

BARI-2D results suggest rosiglitazone may not cause CV events Posted: 07 Jul 2010 05:00 PM PDT New results from a post-hoc analysis of the BARI-2D trial show no association between rosiglitazone and cardiovascular events.

Moderate-dose aspirin linked to lower all-cause mortality in diabetics Posted: 07 Jul 2010 05:00 PM PDT Results from a meta-analysis show that moderate-dose aspirin can significantly reduce all-cause mortality in diabetic patients.

No cardiac, pulmonary dysfunction found in ticagrelor-induced dyspnea Posted: 07 Jul 2010 05:00 PM PDT Ticagrelor therapy can cause a transient and reversible dyspnea in patients free from active lung disease without affecting their cardiac or pulmonary function, researchers suggest.

INVEST in print: Tight diabetic BP control not linked to improved CVD outcomes Posted: 07 Jul 2010 05:00 PM PDT Maintaining the systolic blood pressures of patients with diabetes and coronary artery disease at less than 130 mmHg instead of between 130 and 140 mmHg, does not improve cardiovascular outcomes, researchers report.

Preferences of older breast cancer patients linked to chemotherapy rate Posted: 07 Jul 2010 05:00 PM PDT A strong preference for chemotherapy and good patient–physician communication are associated with higher rates of chemotherapy use in older women with breast cancer, US research shows.

Modulating miR-145 could destroy prostate cancer cells Posted: 06 Jul 2010 05:00 PM PDT US researchers have shown that modulation of microRNA-145 in prostate cancer cells leads to up-regulation of the pro-apoptotic gene TNFSF10, and thus could be an important therapeutic approach in the management of prostate cancer.

Bone metastasis occurs in post-surgery prostate patients, even at low PSA Posted: 06 Jul 2010 05:00 PM PDT Bone metastasis in surgically treated prostate cancer patients can occur even when their prostate-specific antigen levels are low, show US study results.

Breast cancer chemotherapy linked to cognitive dysfunction Posted: 06 Jul 2010 05:00 PM PDT US researchers report that chemotherapy for breast cancer is associated with both acute and late onset cognitive dysfunction, with learning and memory, executive function, and processing speed the worst affected domains.

HIFU for prostate cancer shows promising oncologic outcomes Posted: 05 Jul 2010 05:00 PM PDT Local control of prostate cancer and disease-free survival are as good after high-intensity focused ultrasound as they are after external beam radiotherapy, show French study results.

New drug shows promise for <i>BRCA</i>-related cancers Posted: 05 Jul 2010 05:00 PM PDT A new drug that targets BRCA-deficient cells has antitumor activity in women with advanced breast or ovarian cancer who carry the BRCA1 or BRCA2 gene mutations, shows research published in The Lancet.

Undetectable ultrasensitive PSA predicts recurrence-free survival in RP patients Posted: 04 Jul 2010 05:00 PM PDT Men with an undetectable ultrasensitive prostate-specific antigen nadir after undergoing radical prostatectomy have significantly better 3-year biochemical recurrence-free survival rates than those with detectable nadirs, report researchers.

Heterocyclic amines not linked to prostate cancer across ethnicities Posted: 04 Jul 2010 05:00 PM PDT Despite hypothesizing to the contrary, researchers have found no significant association between the heterocyclic aromatic amines found in well-done meat and an increased risk for prostate cancer.

Complementary medicine use documented in women with breast cancer Posted: 04 Jul 2010 05:00 PM PDT The use of complementary and alternative medicines by women with breast cancer increases with time from diagnosis and is associated with more severe menopausal symptoms, Australian researchers report.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610